Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis

BACKGROUND: Data on the treatment of patients with hepatitis C virus (HCV)/human immunodeficiency virus (HIV) coinfection remains limited. A comprehensive analysis was performed to evaluate the efficacy and safety of ombitasvir (OBV)/paritaprevir (PTV)/ritonavir(r) ± dasabuvir (DSV) ± ribavirin (RBV...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jingjing, Huang, Peng, Fan, Haozhi, Tian, Ting, Xia, Xueshan, Fu, Zuqiang, Wang, Yan, Ye, Xiangyu, Yue, Ming, Zhang, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337763/
https://www.ncbi.nlm.nih.gov/pubmed/30654809
http://dx.doi.org/10.1186/s12985-018-1114-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337763/
https://www.ncbi.nlm.nih.gov/pubmed/30654809
http://dx.doi.org/10.1186/s12985-018-1114-4

Ejemplares similares